Challenging Statin Intolerance: Back to Basics

NLA on Statin Intolerance

Ask Yourself: What Is the Cause?

Spectrum of Statin-Associated Muscle Adverse Events

Incidence/Prevalence of Statin Intolerance

Rethinking Statins

Not All Statins Are Created Equal

Statins: High/Medium/Low

CYP450

Statin Pharmacokinetics

Pitavastatin and Pravastatin: Minimal CYP Involvement

Drugs That Interfere With Statin Medications

Human Cytochrome P450 Isoenzymes Known to Oxidize Clinically Used Drugs

Metabolizing Enzymes and Transporters Involved in Statin Drug-Drug Interactions

Gemfibrozil With Statin Drug-Drug Interactions

NLA Recommendations What Should Providers Do?

Let the Patient Tell You About Their Symptoms

NLA Recommendations: Consistent With Those Found in the ACC's Tool

Myth Busters

2015 ACC Health Policy Statement Team Management

Abbreviations